[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.226.244.70. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
June 2, 1951

EVALUATION OF NEW DRUGS

Author Affiliations

Vice President, University of Texas, for the Medical Branch, Galveston.

JAMA. 1951;146(5):495. doi:10.1001/jama.1951.03670050077025

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

To the Editor:  —It is pertinent to keep the published record clear regarding the standards and ideals of scientists and physicians of the United States. Especially is this necessary in matters involving new and allegedly useful methods of handling disease. Distressing, therefore, is the spectacle of reputable scientific medical men promoting persuasive but dubious arguments and evidence on a material for use in cancer which has suspicious commercial association and on which satisfactory chemical analysis or pharmacological appraisal has not yet been issued in customary scientific or medical publications.Those who would like to know what technical procedures are available for the reasonably satisfactory introduction of new therapeutic agents may refer to the following publications: "The Pharmacologic Evaluation of New Drugs" (J. A. M. A. 93:1632 [Nov. 23] 1929); "Laboratory and Clinical Appraisal of New Drugs" (J. A. M. A. 126:958 [Dec. 9] 1944); "Current Pharmacology: General Principles

First Page Preview View Large
First page PDF preview
First page PDF preview
×